121 related articles for article (PubMed ID: 10571732)
1. Human keratinocytes constitutively express interleukin-18 and secrete biologically active interleukin-18 after treatment with pro-inflammatory mediators and dinitrochlorobenzene.
Naik SM; Cannon G; Burbach GJ; Singh SR; Swerlick RA; Wilcox JN; Ansel JC; Caughman SW
J Invest Dermatol; 1999 Nov; 113(5):766-72. PubMed ID: 10571732
[TBL] [Abstract][Full Text] [Related]
2. Modulation of keratinocyte-derived interleukin-8 which is chemotactic for neutrophils and T lymphocytes.
Barker JN; Jones ML; Mitra RS; Crockett-Torabe E; Fantone JC; Kunkel SL; Warren JS; Dixit VM; Nickoloff BJ
Am J Pathol; 1991 Oct; 139(4):869-76. PubMed ID: 1681733
[TBL] [Abstract][Full Text] [Related]
3. Aspects of interleukin-8 gene expression by gingival and dermal fibroblasts stimulated with interleukin-1beta or tumour necrosis factor alpha.
Myokai F; Koyama E; Nishikawa K; Noji S; Murayama Y; Taniguchi S
J Int Acad Periodontol; 2004 Jan; 6(1):21-8. PubMed ID: 14964491
[TBL] [Abstract][Full Text] [Related]
4. Keratinocyte CDw60 expression is modulated by both a Th-1 type cytokine IFN-gamma and Th-2 cytokines IL-4 and IL-13: relevance to psoriasis.
Huang BB; Bonish BK; Chaturvedi V; Qin JZ; Nickoloff BJ
J Invest Dermatol; 2001 Feb; 116(2):305-12. PubMed ID: 11180008
[TBL] [Abstract][Full Text] [Related]
5. HUT 78 T cells bind to noncytokine-stimulated keratinocytes using a non-CD18-dependent adhesion pathway.
Nickoloff BJ; Mitra RS; Shimizu Y; Barker JN; Karabin G; Stoof T; Stoolman LM
Am J Pathol; 1992 Jun; 140(6):1365-74. PubMed ID: 1351368
[TBL] [Abstract][Full Text] [Related]
6. Localization of calcineurin/NFAT in human skin and psoriasis and inhibition of calcineurin/NFAT activation in human keratinocytes by cyclosporin A.
Al-Daraji WI; Grant KR; Ryan K; Saxton A; Reynolds NJ
J Invest Dermatol; 2002 May; 118(5):779-88. PubMed ID: 11982754
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of interleukin-13 receptor alpha1 on human keratinocytes in the skin of psoriasis and atopic dermatitis.
Wongpiyabovorn J; Suto H; Ushio H; Izuhara K; Mitsuishi K; Ikeda S; Nakao A; Okumura K; Ogawa H
J Dermatol Sci; 2003 Oct; 33(1):31-40. PubMed ID: 14527737
[TBL] [Abstract][Full Text] [Related]
8. Induction of PDGF-B in TCA-treated epidermal keratinocytes.
Yonei N; Kanazawa N; Ohtani T; Furukawa F; Yamamoto Y
Arch Dermatol Res; 2007 Nov; 299(9):433-40. PubMed ID: 17724602
[TBL] [Abstract][Full Text] [Related]
9. Cellular localization of interleukin-8 and its inducer, tumor necrosis factor-alpha in psoriasis.
Nickoloff BJ; Karabin GD; Barker JN; Griffiths CE; Sarma V; Mitra RS; Elder JT; Kunkel SL; Dixit VM
Am J Pathol; 1991 Jan; 138(1):129-40. PubMed ID: 1702929
[TBL] [Abstract][Full Text] [Related]
10. Lesional psoriatic T cells contain the capacity to induce a T cell activation molecule CDw60 on normal keratinocytes.
Skov L; Chan LS; Fox DA; Larsen JK; Voorhees JJ; Cooper KD; Baadsgaard O
Am J Pathol; 1997 Feb; 150(2):675-83. PubMed ID: 9033280
[TBL] [Abstract][Full Text] [Related]
11. Membrane interleukin 1 induction on human endothelial cells and dermal fibroblasts.
Kurt-Jones EA; Fiers W; Pober JS
J Immunol; 1987 Oct; 139(7):2317-24. PubMed ID: 3116078
[TBL] [Abstract][Full Text] [Related]
12. Keratinocytes from patients with atopic dermatitis and psoriasis show a distinct chemokine production profile in response to T cell-derived cytokines.
Giustizieri ML; Mascia F; Frezzolini A; De Pità O; Chinni LM; Giannetti A; Girolomoni G; Pastore S
J Allergy Clin Immunol; 2001 May; 107(5):871-7. PubMed ID: 11344355
[TBL] [Abstract][Full Text] [Related]
13. Cultivated ginseng inhibits 2,4-dinitrochlorobenzene-induced atopic dermatitis-like skin lesions in NC/Nga mice and TNF-α/IFN-γ-induced TARC activation in HaCaT cells.
Choi JH; Jin SW; Park BH; Kim HG; Khanal T; Han HJ; Hwang YP; Choi JM; Chung YC; Hwang SK; Jeong TC; Jeong HG
Food Chem Toxicol; 2013 Jun; 56():195-203. PubMed ID: 23454147
[TBL] [Abstract][Full Text] [Related]
14. Expression of tenascin-C splice variants by human skin cells.
Latijnhouwers MA; de Jongh GJ; Bergers M; de Rooij MJ; Schalkwijk J
Arch Dermatol Res; 2000 Sep; 292(9):446-54. PubMed ID: 11000288
[TBL] [Abstract][Full Text] [Related]
15. Monocyte chemotaxis and activating factor production by keratinocytes in response to IFN-gamma.
Barker JN; Jones ML; Swenson CL; Sarma V; Mitra RS; Ward PA; Johnson KJ; Fantone JC; Dixit VM; Nickoloff BJ
J Immunol; 1991 Feb; 146(4):1192-7. PubMed ID: 1899440
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-17 and interferon-gamma synergize in the enhancement of proinflammatory cytokine production by human keratinocytes.
Teunissen MB; Koomen CW; de Waal Malefyt R; Wierenga EA; Bos JD
J Invest Dermatol; 1998 Oct; 111(4):645-9. PubMed ID: 9764847
[TBL] [Abstract][Full Text] [Related]
17. Release of soluble ICAM-1 from human lung fibroblasts, aortic smooth muscle cells, dermal microvascular endothelial cells, bronchial epithelial cells, and keratinocytes.
Leung KH
Biochem Biophys Res Commun; 1999 Jul; 260(3):734-9. PubMed ID: 10403835
[TBL] [Abstract][Full Text] [Related]
18. Dendritic cells express hematopoietic prostaglandin D synthase and function as a source of prostaglandin D2 in the skin.
Shimura C; Satoh T; Igawa K; Aritake K; Urade Y; Nakamura M; Yokozeki H
Am J Pathol; 2010 Jan; 176(1):227-37. PubMed ID: 20008150
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-17 is produced by both Th1 and Th2 lymphocytes, and modulates interferon-gamma- and interleukin-4-induced activation of human keratinocytes.
Albanesi C; Scarponi C; Cavani A; Federici M; Nasorri F; Girolomoni G
J Invest Dermatol; 2000 Jul; 115(1):81-7. PubMed ID: 10886512
[TBL] [Abstract][Full Text] [Related]
20. Human keratinocytes constitutively produce but do not process interleukin-18.
Mee JB; Alam Y; Groves RW
Br J Dermatol; 2000 Aug; 143(2):330-6. PubMed ID: 10951141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
